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Evidence for a role of epithelial mesenchymal transition during
pathogenesis of fistulae in Crohn's disease
Abstract
BACKGROUND: The pathogenesis of fistulae in Crohn's disease (CD) patients is barely understood.
We recently showed that more than two-thirds of CD fistulae are covered with flat, mesenchymal-like
cells (transitional cells [TC]) forming a patchy basement membrane. Epithelial-to-mesenchymal
transition (EMT) is a process of reprogramming epithelial cells, allowing them to migrate more
effectively and giving epithelial cells an "invasive" potential. EMT has been suggested to be crucial in
fibrosis found in different tissues and diseases. We therefore investigated whether EMT could be
involved in the pathogenesis of fistulae formation in CD. METHODS: In all, 18 perianal fistulae, 2
enteroenteric, and 1 enterovesical fistulae from 17 CD patients were analyzed. In addition 2 perianal
fistulae of non-CD patients were studied. Hematoxylin and eosin staining, immunohistochemistry for
the expression of cytokeratins 8 and 20, beta6-integrin, E-cadherin, beta-catenin, vimentin, and
TGF-beta1 and 2 were performed according to standard techniques. RESULTS: The TC covering
perianal or enteroenteric fistulae were strongly positive for cytokeratins 8 and 20 but negative for
vimentin, indicating their epithelial origin. beta6-Integrin and TGF-beta had the highest staining
intensities in the transitional zone between the epithelium and the TC. Expression of junctional proteins
such as E-cadherin was reduced in TC as compared to regular fistulae epithelium. In addition, a
translocation of beta-catenin from the membrane to the cytoplasm was observed. CONCLUSIONS: Our
data for the first time indicate an expression pattern of epithelial and mesenchymal markers in TC
associated with fistulae formation that is characteristic for EMT. Studying the pathways of EMT during
intestinal fistulae formation may help to develop new therapeutic strategies.
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Abstract 
BACKGROUND: The pathogenesis of fistulae in Crohn’s disease (CD) patients is 
barely understood. We could recently show that more than 2/3 of CD fistulae are 
covered with flat, mesenchymal-like cells (transitional cells; TC) forming a patchy 
basement membrane. Epithelial-to-mesenchymal transition (EMT) is a process of re-
programming epithelial cells allowing them to migrate more effectively and giving 
epithelial cells an “invasive” potential. EMT has been suggested to be crucial in 
fibrosis found in different tissues and diseases. We therefore investigated, whether 
EMT could be involved in the pathogenesis of fistulae formation in CD. 
METHODS: 18 perianal fistulae, two entero-enteric and one entero-vesical fistulae 
from 17 CD patients were analysed. In addition 2 perianal fistulae of non-CD patients 
were studied. H&E staining, immunohistochemistry for the expression of cytokeratins 
8 and 20, β6-integrin, E-cadherin, β-catenin, vimentin and TGF-β1 and 2 were 
performed according to standard techniques.  
RESULTS: The TC covering perianal or entero-enteric fistulae were strongly positive 
for cytokeratins 8 and 20, but negative for vimentin indicating their epithelial origin. 
ß6-integrin and TGF-β had highest staining intensities in the transitional zone 
between the epithelium and the TC. Expression of junctional proteins such as E-
cadherin was reduced in TC as compared to regular fistulae epithelium. In addition a 
translocation  of β-catenin from the membrane to the cytoplasm was observed. 
CONCLUSION: Our data for the first time indicate an expression pattern of 
epithelial and mesenchymal markers in TC associated with fistulae formation which is 
characteristic for EMT. Studying the pathways of EMT during intestinal fistulae 
formation may help to develop new therapeutic strategies. 
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Introduction 
Fistulae are a frequent and serious complication of patients with Crohn’s disease 
(CD). The cumulative incidence in population based studies ranges from 17 up to 50 
% 1-4. The clinical management of CD-fistulae remains a major therapeutic challenge. 
Medical treatment is mainly based on antibiotics and immunosuppressants such as 
azathioprine, cyclosporine A, tacrolimus or infliximab 3, 5-8. However, an initially 
successful closure of fistulae can only be maintained in about 30 to 40 % of patients 
after 12 months. Despite the clinical importance of the problem the pathogenesis of 
fistulae-formation is poorly understood and investigations focussed on the etiology of 
fistulae are sparse. A better knowledge of the pathophysiology of fistulae-formation 
would be crucial for the development of new and more effective therapeutic options.  
It is generally assumed that tissue destruction is the first step in the pathogenesis of 
fistula formation. To gain further insights into fistula formation we 
histomorphologically characterized fistulae resected from CD patients and patients 
without the diagnosis of inflammatory bowel disease (IBD) 9. Ninety-seven fistulae of 
an unselected patient cohort of 78 patients were investigated. Eighty-four fistula 
specimens were derived from 67 CD patients. The results were compared to 13 
fistulae of 11 patients without IBD. Histologically all fistulae showed a central fissure 
penetrating through the lamina propria and the muscularis mucosae into the deeper 
layers of the underlying tissue. All fistulae were surrounded by a granulation tissue 
with histiocytes and a tight network of capillaries. In patients with CD, the interior 
wall of the studied fistulae usually was infiltrated by CD45RO positive T cells, 
followed by a small band of CD68 positive macrophages. At the outer fistulae wall, 
there was a dense infiltrate of CD20 positive B cells.  
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31 % of the „control fistulae“ (i.e. non-IBD) and 27 % of the CD-fistulae showed a 
layer with easily recognizable epithelial cells. Those cells showed tight junctions and 
a basement membrane. Interestingly the „non-epithelialised“ CD-fistulae - present in 
more than 2/3 of all cases - were covered by a thin layer of myofibroblast-like 
“transitional cells” (TC) with gap junctions. These cells also formed a basement 
membrane-like structure. In a subgroup of specimens a region could be identified in 
which the mucosal epithelial cells seemed to continuously transform into the TC-layer 
9. 
Under physiologic conditions fibroblasts are recruited to the sites of tissue injury 10, 
11. However, we recently showed that the migratory potential of CD mucosal 
fibroblasts is reduced compared to controls 12-14 . An even stronger reduction of 
migratory ability was found in fibroblasts derived from CD fistula tissue (unpublished 
data) indicating a disturbance in wound healing. Epithelial cell migration is an 
another hallmark of the attempt of the intestinal mucosa to rapidly close defects of 
the intestinal barrier 15-21. It is induced by a number of different growth factors 20. 
However, epithelial cells migrate slowly. If a superficial tissue defect of the mucosa 
cannot be closed by intestinal fibroblasts epithelial cells might migrate towards the 
defect. 
 
Recent evidence suggests that epithelial cells do not represent a final and irreversible 
state of differentiation. Conversion of an epithelial cell to a mesenchymal cell has 
been shown to be critical during embryogenesis and is a structural feature of organ 
development. Current interest in this process – called epithelial–to-mesenchymal 
transition (EMT) - has increased due to its involvement in adult pathologies 22, 23. It 
has been proposed that epithelial tumours undergo EMT, facilitating their invasion. 
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EMT is also an essential component of tissue remodelling, and wound repair 23-27. 
During this transition, the epithelial cells - characterized by strong cell-cell junctions 
and polarity - are replaced by a mesenchymal phenotype, with reduced cell-cell 
adhesions, a fibroblast morphology and function 22, 23, 28. There are several molecular 
markers for the detection of EMT in vivo 22, 23. These include decreased E-cadherin 
and β-catenin expression, and increased expression of β6 integrin 29, 30. During EMT 
β-catenin translocates to the nucleus. TGF-β has been shown to be an inducer of 
EMT.  
We hypothesized that EMT could be important in the pathophysiology of fistula 
development in CD. Adhesions between mesenchymal cells are less tight than 
between epithelial cells facilitating an increased migratory capacity. Epithelial cells 
undergoing EMT have an increased migratory potential independently of cell-cell 
contacts 22. To test our hypothesis we used fistula specimens of patients with CD for 
immunohistochemical staining of EMT markers. In addition we established primary 
fibroblast cultures from CD patients with and without fistulae. Here we present first 
time evidence for EMT in intestinal wound healing and the pathogenesis of fistulae in 
CD. 
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Materials and Methods 
 
Patients 
18 entero-cutaneous fistula specimens from 15 patients were examined 
retrospectively. In addition we studied 2 perianal fistulae from patients without CD. 
This series was obtained from unselected cases at the Institute of Pathology of the 
University of Regensburg. Specimens had been surgically removed between August 
1993 and May 2003. 14 CD fistula specimens showed flat TC covering the fistula 
walls, 4 fistulae had a squamous cell layer. The two non-CD fistulae also showed flat 
TC cells covering the fistula tract. In addition, two entero-enteric and one entero-
vesical fistulae from 2 patients were investigated. Those two patients underwent 
surgery in December 2008 at the University Hospital of Zurich. Those fistulae had a 
columnar epithelium at the opening and flat mesenchymal like cells along the fistula 
tracts.  
The diagnosis of CD was based on established clinical, endoscopic, histological and 
radiological parameters 31, 32. Details on fistula distribution, patient age at 
presentation and patient gender are shown in table 1.  
The degree of inflammation was graded microscopically by determination of the 
inflammatory infiltrate of neutrophils, eosinophils and lymphocytes: 0 = no 
inflammation, 1 = low degree of inflammation, 2 = severe inflammation.  
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This study was approved by the Ethics Committee of the University of Regensburg 
and performed according to the declaration of Helsinki. 
 
Specimen preparation 
Tissue specimens were fixed in 4% buffered formalin for at least 24 h and embedded 
in paraffin. Sections of approximate 2 – 3 µm thickness were cut from tissue blocks 
and stained with H&E (haematoxylin and eosin) according to standard protocols.  
 
Immunohistochemistry 
Immunohistochemical studies for the expression of cytokeratins 8 and 20, β6-
integrin, TGF-β, E-cadherin, β-catenin and vimentin were performed on 17 fistulae of 
15 patients with CD by using an avidin-biotin peroxidase method with 
diaminobenzidine (DAB) chromogen. After antigen retrieval (microwave treatment of 
formalin-fixed, paraffin-embedded 2-3 µm tissue sections for 40 min at 240 W in 
citrate buffer, pH 6.0) immunohistochemistry was carried out in a NEXES 
immunostainer (Ventana Medical System, Tucson, AZ) according to the 
manufacturer´s instructions. As primary antibodies mouse monoclonal and rabbit 
polyclonal antibodies were used (ß-catenin [Santa Cruz, SC-7963, mouse monoclonal 
(E-5), dilution 1:50]; E-cadherin [Santa Cruz, SC-8426, mouse monoclonal (G-10), 
dilution 1:75]; TGF-ß2 [Santa Cruz (SC-90), rabbit polyclonal, dilution 1:30]; TGF-ß1 
[Acris (DM1047), mouse (TB21) monoclonal, dilution 1:200]; CK8 [Dako M0631), 
mouse (35ßH11) monoclonal, dilution 1:50], CK20 [Progen (61026), mouse 
(ITKS20.8) monoclonal, dilution 1:10]). After incubation for 24 min at 37° C, the 
slides where rinsed in PBS, and incubated with the secondary antibody (rabbit-anti-
mouse; Ventana Medical System, 1:500 dilution in PBS) for 2 h at room temperature. 
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Antibody binding was visualized with 0.05% DAB (Ventana Medical System), and 
0.01% hydrogen peroxide. The material was rinsed in PBS and counterstained with 
haematoxylin. For integrin β6 staining, antigen retrieval was performed using 
incubation in pepsin solution [Zymed Laboratories Inc.] at 37°C, prior to overnight 
incubation with the monoclonal antibody 2G2 (Biogen-Idec, 2 ug/ml). 
Three different pathologists (F. Bataille, R. Bates, A Weber) evaluated the specimens 
according to subjective criteria and graded the expression into three different 
categories (0 = no expression; 1 = weak expression and 2 = strong expression). The 
results of this evaluation were consistent. 
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Results 
We evaluated differences in the expression of specific antigens between the cells of 
origin (intestinal columnar epithelium or squamous cell epithelium) and the TC by 
immunohistochemistry. 14 perianal fistulae with intestinal epithelium, two entero-
enteric, one entero-vesical fistulae, four perianal fistulae with squamous cell 
epithelium from CD patients and two perianal fistulae from non-IBD patients were 
investigated. The expression of the respective antigen staining intensity was semi-
quantitatively rated as “absent” (0), „weak“ (1) or „strong“ (2). A median was 
calculated and used for the comparison of the two fistula areas. 
 
E-Cadherin 
During the process of EMT a loss or reduction of E-cadherin expression is well known 
to occur 33-37. E-cadherin is involved in homophilic interactions between epithelial 
cells and is necessary for the formation of zonulae adherentes. In the normal 
intestinal epithelial cells E-cadherin staining was found at the lateral cell membrane 
at the cell-cell contact sites. In the fistulae lining cells a decrease in the intensity of 
staining was found (Figure 1). In 64.3% of the specimens additionally a 
redistribution of the membranous E-cadherin was found giving the staining at the cell 
wall a scattered appearance. Comparable observations were made in fistulae 
containing a squamous cell layer. A decrease in the median from weak staining to 
virtually absent staining was noted. With higher magnification it became evident that 
the pattern of E-cadherin expression in the fistula lining cells was dependent on the 
distance of the cells from the origin of the fistula in the gut lumen. Figure 2 clearly 
shows that cells closer to the mucosa (Figure 2A and B) have a more regular 
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expression of E-cadherin than cells from deeper areas of the fistula (Figure 2C and 




The process of EMT is characterized by a re-distribution of β-catenin 38-42. Initially 
during EMT β-catenin expression is increased, however, the protein is no longer 
membrane associated but localized in the cytoplasm or even in the nucleus. In the 
later stages of EMT the synthesis of β-catenin is reduced. As expected we found a 
strong staining of the lateral cell membrane of the columnar normal mucosal 
intestinal epithelial cells (Figure 3 A, B and D). In the TC a diffuse and much 
weaker expression was found, which was localized cytoplasmatically (Figure 3 B, C 
and D). Comparable findings were obtained in the four fistulae with a squamous cell 
epithelial layer (Figure 3 E). The staining was much stronger in the regular epithelia 
compared to TC (Figure 3 G and H). 
 
Cytokeratin 8 and 20 
Cytokeratin 8 (CK 8) is an intermediate filament and part of the cytoskeleton of 
intestinal epithelial cells 43. We used this typical epithelial marker to evaluate its 
expression in the flat TC covering the deeper areas of fistulae. In the 14 fistulae 
containing intestinal epithelial cells and TC no difference between the two cell 
populations with respect to CK 8 expression was observed (Figure 4). In the four 
specimens that contained a squamous cell layer a difference was noted. The 
squamous epithelial cells did not express CK 8 whereas in the fistula lining cells a 
median staining intensity of 1.5 was found. 
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Comparable results were found for cytokeratin 20 (CK 20). Intestinal epithelial cells 
as well as TC were strongly positive for CK 20 (data not shown).  
 
Vimentin 
Vimentin is an intermediate filament and one major component of the cytoskeleton. 
It is abundantly expressed in fibroblasts and endothelial cells 44. We used this typical 
mesenchymal marker to evaluate its expression in the flat TC covering the deeper 
areas of fistulae. In our staining all epithelia – columnar and squamous epithelia as 
well as TC – were negative for vimentin (data not shown). 
 
Integrin β6 
The β6 integrin-chain is restricted to epithelial cells and expressed during embryonic 
development and organogenesis. Re-induction of αvβ6 indicates an important role of 
this receptor during intestinal EMT. Six fistulae were stained with a specific antibody 
for β6 integrin. A clear difference in the intensity of staining between normal 
epithelial and fistulae covering cells could be noted.  As expected virtually no protein 
expression of β6 integrin could be found in normal intestinal epithelial cells. 
Especially in the „transitional zones“, where a stepwise flattening of the epithelial 
cells occurs, a strong staining pattern (Figure 5) was detected.  
 
TGFβ1 and TGFβ2 
TGF is known to play a major role in the induction of EMT and its induction is linked 
to β6 integrin-expression 30, 45-53. Immunohistochemistry for TGFβ1 showed a weak 
staining in the fistula lining cells whereas normal mucosal intestinal epithelial cells 
were negative for TGFβ1. This indicates an induction of TGFβ1 expression in the 
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fistula tract. A clear difference of the medians of expression was found. In specimens 
containing squamous cells a comparable observation was made (data not shown). 
  
Expression of TGFβ2 was weak in normal intestinal epithelial cells. The expression in 
the TC was stronger (Figure 6). Similar observations were made in the four 
specimens containing squamous cells. 
 
Entero-enteric fistulae 
To investigate whether the described features of EMT are generally found in 
“mesenchymal cell” covered CD fistula of specific for perianal fistula we investigated 
two enter-enteric fistulae obtained by surgical resection. The first patient suffered 
from ileo-sigmoidal and ileo-vesical fistulae and the second patient from ileo-ileal 
fistula formation. The Immunohistochemical results in these two fistula patients were 
identical to entero-cutaneous fistulae described above (Figure 7). Cytokeratin 8 and 
cytokeratin 20 were found to be expressed in all fistula lining cells independent of 
whether they had epithelial or mesenchymal morphology (Figure 7 B). E-Cadherin 
expression clearly was associated to cell membranes and cell-cell contacts in the 
beginning of the entero-enteric fistulae tracts. However in the transition zone E-
cadherin expression clearly was reduced or almost absent (Figure 7C, D and E). 
Whereas β-catenin expression was located at cell borders and cell membranes at the 
luminal end of the fistulae (Figure 7 F and G) in the transition zone β-catenin was 
localized in the cytoplasm or in the nucleus (Figure 7H) as described to be typical 
for EMT. These data are indicative for a role of EMT in the formation of entero-
enteric and entero-vesical fistulae. 
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Non-CD fistulae. 
Two specimens from patients without CD were investigated by 
immunohistochemistry with the same antibodies as used above (with the exception 
of β6 integrin). Very similar to the findings indicated above we found evidence for 
EMT in these specimens (data not shown). 
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Discussion 
In the present manuscript we show clear first time evidence for EMT in the epithelial 
transitional zone close to the luminal origin of perianal, entero-cutaneous, entero-
enteric as well as entero-vesical fistulae tracts in CD patients. We provide data that 
the flat TC, that used to be morphologically classified as fibroblasts retain epithelial 
markers such as CK 8 and CK 20, are vimentin negative, show a redistribution of E-
cadherin and β-catenin as described earlier to be typical for EMT and illustrate a re-
induction of markers of early morphogenesis such as β6-integrin. TGF-β is highly 
expressed in the transitional zone between normal intestinal epithelium and fistula 
lining “mesenchymal cells” indicating a potential role during fistula-EMT. We 
therefore hypothesize, that CD fistula form via the TGF driven initiation of EMT which 
so far has only been described in cancer metastasis and tissue fibrosis.  
 
What may be the reason for epithelial cells to undergo EMT during fistula formation? 
Normally regularly spaced cell–cell junctions and adhesions between neighbouring 
epithelial cells hold them together in a tight formation preventing the movement of 
individual cells away from the epithelial monolayer. In contrast, mesenchymal cells 
lack tight intercellular adhesions making them much more mobile followed by an 
increased migratory capacity. Whereas epithelial cells usually move as a sheet en 
block, mesenchymal migration is much more dynamic. Cells move individually and 
can leave part of the trailing region behind 54.  
 
Turning an epithelial cell into a mesenchymal cell requires alterations in morphology, 
cellular architecture, downregulation of cell-cell adhesion systems, and migratory 
capacity. Commonly used molecular markers for EMT include β6-integrin, vimentin 
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and cytokeratin expression, cadherins and nuclear localization of β-catenin. 
 
A defining feature of EMT is a reduction in E-cadherin levels (E for epithelial 
cadherin). Cadherins are transmembrane proteins whose homotypic interaction 
between neighbouring cells creates adherens junctions 26, 55. Alteration of cadherin-
based adhesion has a key role in modulating development, organogenesis or 
turnover of rapidly growing tissues. At the cell membrane, cadherin proteins are 
found as homodimers tethered to the actin cytoskeleton by a multiprotein complex 
that includes α-catenin, β-catenin, and p120-catenin. The presence of E-cadherin in 
epithelial cells allows for greater cell–cell adhesive strength compared with that of 
the N-cadherin–expressing mesenchyme.  
 
β-catenin is the direct physiological link between cadherins and the actin 
cytoskelleton at the adherens junctions. In addition β-catenin has a role as a signal-
transducing molecule influencing the state of the actin cytoskeleton 56. Catenins 
directly modulate the adhesive state of the cadherin extracellular homophilic 
adhesive binding domain and therefore control epithelial adhesion and junctional 
formation in a way similar to integrins 55, 57. The nuclear translocation of β-catenin 
from the cytoplasm is considered a key molecular step in EMT 23. E-cadherin as well 
as β-catenin was down regulated in TC compared to mucosal epithelial cells and 
squamous cells. In addition in 2/3 of the specimens a redistribution of E-cadherin 
with a scattered appearance was detected. β-catenin in TC showed a diffuse 
cytoplasmatic localization in comparison to localization to the lateral cytoplasmic cell 
membrane in squamous epithelial or mucosal epithelial cells. This is clear evidence 
for a disaggregation of the epithelial units and a reshaping for movement.  
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The integrin complexes represent the major receptors that mediate attachment to 
the extracellular matrix, with ligand occupancy triggering intracellular signalling 
pathways 58. The expression of β6-integrin is restricted to epithelial cells. The β6-
chain only associates with the αV subunit. Among the ligands of the aVβ6 complex 
are fibronectin, tenascin, and “TGF-β latency-associated peptide” (LAP). αvβ6 is 
expressed during embryonic development and organogenesis. In adults αvβ6 
expression is only found in few epithelial tissues. Expression of αvβ6 can be re-
induced during specific morphogenetic processes such as inflammation and wound 
healing. Re-induction of αvβ6 during intestinal EMT indicates an important role of 
this receptor in that process. It could be shown that the re-expression of αvβ6 in 
colon carcinoma cell lines is correlated with aggressiveness of metastases and the 
extent of EMT 29, 30. In CD fistulae αvβ6 was solely expressed in TC with the highest 
staining intensity in the transitional zone between regular intestinal epithelium and 
TC. The invasive potential of the EMT cells could explain why fistulae similar to 
carcinoma cells are relatively aggressive. EMT in the context of fistula formation, 
however, differs from EMT found during tumour metastasis as in the case of fistulae 
normal, non-transformed cells undergo this change in differentiation. 
 
TGF-β has been shown to be a key inducer and an important regulator of EMT. The 
TGF-β effect on EMT activation depends on β-integrin transduction 23. The effect of 
TGFβ typically is either mediated via a Smad3-dependent regulation of transcription 
or a Smad3-independent, p38MAP-kinase-activation and GTPase-mediated signalling 
45, 50, 53, 59, 60. The induction of β6 integrin expression is likely to be involved in the 
induction of autocrine TGF secretion 30, 49. In concordance with this TGF was stronger 
expressed in the TC versus squamous cells or mucosal epithelial cells. 
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Usually an induction of vimentin expression has been associated with EMT. Thus, the 
characteristics of the TCs fit most but not all criteria for EMT. However, there is no 
clear consensus in the literature defining the use of the term EMT. Therefore, we 
suggest that our lesser stringent definition of EMT is appropriate.  
 
The specific pathogenesis of fistulae in CD is not known. There is a body of data 
suggesting a persistent functional change of intestinal myofibroblasts isolated from 
inflamed CD compared to controls. This is accompanied by a reduction of FAK protein 
and FAK phosphorylation, which may be responsible for the reduced migratory 
capacity of CD-myofibroblasts and TNF/IFN-γ treated cells 13. The reduced ability of 
inflammation-modified CD myofibroblast to close ulcers and deep tissue defects may 
force epithelial cells to undergo EMT and become rapidly moving and “invasive” to 
re-establish an epithelial layer and consecutively the mucosal barrier. 
 
In summary our data indicate a change in phenotype of intestinal mucosal and 
squamous epithelial cells into TC. Staining for markers of EMT provides evidence for 
this mechanism in perianal, entero-cutaneous, entero-enteric and entero-vesical 
fistulae. The functional characteristics of EMT, such as increased capacity for 
migration and three-dimensional invasion by downregulation of molecules, which 
promote epithelial integrity, might be an attempt of the intestinal non-immune cells 
to close the mucosal defects, however in this case with a detrimental effect. The 
presence of similar results in non-CD fistulae implies that EMT may not only be 
involved in fistula formation in CD. This indicates that EMT may be a general feature 
of histologically similar fistulae, regardless of their etiology. 
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It will be important to further understand the mechanisms of EMT in the 
pathophysiology of fistula formation. This study opens a new area of research. 
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Figure legends 
Figure 1. Expression of E-cadherin in CD fistulae 
The regular mucosal epithelial cells (black arrow) showed a stronger expression of E-
cadherin, compared to the transitional zone and the TC (red arrow; A, B). 2/3 of the 
specimens showed a scattered appearance of the fistula epithelium (B). In the TC 
originating from the squamous epithelial cells no E-cadherin expression was noted 
(C). The negative control is shown in figure D. Semi-quantitative analysis of the 
staining intensity revealed a clearly higher expression of E-cadherin in the mucosal 
epithelial cells versus the TC (E). Epithelial cells from the specimen with the 
squamous epithelial lining expressed E-cadherin with a lower intensity, which was 
even lower in TC (F). 
 
Figure 2. Change of the pattern of expression of E-cadherin in CD fistulae 
The pattern of E-cadherin expression in the fistula lining cells was dependent on the 
distance of the cells from the origin of the fistula in the gut lumen. Cells closer to the 
mucosal surface show a more regular expression of E-cadherin (A and B) than cells 
from deeper areas of the fistula (C and D). E:  typical “transition zone” showing this 
change of localization of E-cadherin staining. (A, C, D and E: magnification x 200; C: 
magnification x 400). 
 
Figure 3. Expression of β-catenin in CD fistulae 
The regular mucosal epithelial cells (black arrow) showed a strong expression of β-
catenin, which was located at the cell membrane. The TC however (red arrow) 
express lower amount of β-catenin, which was mainly fragmented in the cytoplasm 
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(A – D). The same observation could be made for fistulae with a squamous cell 
epithelial origin (E). The negative control is shown in figure F. Semi-quantitative 
analysis of the staining intensity revealed a higher expression of β-catenin in the 
mucosal epithelial cells versus the TC (G). The same observation could be made for 
fistulae with a squamous cell epithelial origin (H). 
 
Figure 4. Expression of cytokeratin 8 in CD fistulae 
The mucosal epithelial cells (black arrow) as well as the TC lining the fistula lumen 
(red arrow) are strongly positive for cytokeratin 8 (A - D; C: same specimen as 
shown in Figure 3C). In D the transition zone with more flat cells to the lower right 
corner is clearly visible without reduction of CK 8 expression. The TC, which 
originated from squamous epithelial cells were also positive for cytokeratin 8 (E). The 
negative control is shown in figure F. Squamous epithelial cells did not express 
cytokeratin 8 versus a median expression of 1.5 in TC. 
 
Figure 5. Expression of β6 integrin in CD fistulae 
The regular mucosal epithelial cells (black arrow) did not express β6 integrin, 
whereas the staining in the transitional zone (red arrow) is strongly positive (A - D).  
A higher magnification (areas from panel D) clearly shows the difference in staining 
intensity between TC cells (left) and normal epithelium (right). The isotype control 
did not show any staining (data not shown). Semi-quantitative analysis of the 
staining intensity revealed a clearly higher expression of β6 integrin at the 
transitional zone versus the regular mucosal epithelium (F). 
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Figure 6. Expression of TGFβ2 in CD fistulae 
The regular mucosal epithelial cells (black arrow) showed a weak expression of 
TGFβ2, whereas the staining of the TC (red arrow) was strongly positive for TGFβ2 
(A). In panel B a higher magnification of the fistula lining cells and in C of a normal 
crypt is shown to clearly demonstrate the difference in immunohistochemical 
staining. The same observation was made for fistulae with a squamous cell epithelial 
origin (D). Semi-quantitative analysis of the staining intensity revealed a higher 
expression of TGFβ2 at the transitional zone versus the regular mucosal epithelium 
and the squamous epithelium (E, F). 
 
Figure 7. Evidence for EMT in an entero-enteric fistula 
A: H&E staining of an entero-enteric fistula. The fistula origin is to the upper left.  B: 
Cytokeratin 8 is expressed in all fistula lining cells, even in regions were they are flat 
and no longer columnar with a more mesenchymal-like morphology. E-Cadherin 
expression was associated to cell membranes and cell-cell contacts in the beginning 
of the fistula. However in the transition zone E-cadherin expression clearly was 
reduced (C). Higher magnifications (D and E) indicate this difference. Whereas b-
catenin expression also could be located to cell borders and cell membranes at the 
beginning of the fistula (F and higher magnification in G) in the transition zone β-
catenin was localized in the cytoplasm or even in the nucleus (H) as described to be 
typical for EMT.  
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Characteristics of the fistulae investigated in this study. 
 
Age of patient 
at 
presentation 
gender localisation of fistula 
Entero-cutaneous, CD patients 
46 f ileum 
67 f ileum 
17 m left sided colon 
24 m terminal ileum 
37 m terminal ileum 
23 f cecum 
20 m sigmoid colon 
20 m sigmoid colon 
48 f colon 
42 f ileum 
24 m ileum 
40 m ileum 
37 f perianal 
27 f ileum 
71 m perianal 
39 f perianal 
24 f perianal 
35 m perianal 
Entero-enteric and entero-vesical, CD patients 
52 m Ileum – sigmoid colon (entero-
enteric) 
and ileum-bladder (entero-vesical)
19 m Ileum-ileum (entero-enteric) 
Entero-cutaenous, non IBD patients 
48 m perianal 
56 m perianal 
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